Delivery Order SPE2DB20D1004-SPE2DB24FF7J8
- Not listed
- This federal contract award is for the delivery of CLONIDINE HCL ER 0.1 MG TABLET 60S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,048.26 and an ultimate completion date of May 3, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,900.30 firm fixed-price delivery order is for the supply of 4562815802 - Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has an ultimate completion date of November 15, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $3,082.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a generic pharmaceutical product. The contract has an ultimate completion date of October 28, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,933.55 firm fixed-price delivery order is for the supply of 60-count tablets of Clonidine HCL ER 0.1 mg, a medication used to treat high blood pressure and certain mental health conditions. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,460.48 firm-fixed-price delivery order is for the supply of 4565250057 - Clonidine HCL ER 0.1 mg Tablets, with a period of performance through July 26, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,947.80 Delivery Order is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award is a delivery order made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The award is valued at $1,089.14 and has a performance period that extends to July 29, 2024. This contract is a firm fixed-price delivery order awarded under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,027.41, with an ultimate completion date of October 16, 2024. No set-aside designation was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,006.82 firm fixed price delivery order is for the supply of Clonidine Hydrochloride Extended Release 0.17 mg Tablets in 30-count packages. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.85, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a firm fixed-price delivery order with a performance period ending on December 15, 2023. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF7J8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,756.63, for the delivery of the pharmaceutical product Clonidine HCL ER 0.1 mg Tablet 60s. The ultimate completion date for this contract is April 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract, which runs through December 31, 2025, enables the DLA to efficiently procure essential medications and medical commodities for military and veteran healthcare needs. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. The contract award did not have a set-aside designation, indicating it was awarded through full and open competition. The contract supports the high-level programs of the DLA, which is responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces, other government agencies, and partner nations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/2/24 |